On Invalid Date, Sana Biotechnology (NASDAQ: SANA) reported Q4 2023 earnings per share (EPS) of -$0.45, up 7.14% year over year. Total Sana Biotechnology earnings for the quarter were -$88.12 million. In the same quarter last year, Sana Biotechnology's earnings per share (EPS) was -$0.42.
As of Q2 2024, Sana Biotechnology's earnings has grown year over year. Sana Biotechnology's earnings in the past year totalled -$283.26 million.
What is SANA's earnings date?
Sana Biotechnology's earnings date is Invalid Date. Add SANA to your watchlist to be reminded of SANA's next earnings announcement.
What was SANA's revenue last quarter?
On Invalid Date, Sana Biotechnology (NASDAQ: SANA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Sana Biotechnology's revenue was $0.00.
What was SANA's revenue growth in the past year?
As of Q2 2024, Sana Biotechnology's revenue has grown null year over year. Sana Biotechnology's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.